Published in Stroke on September 07, 2006
The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53
Autoimmune responses to the brain after stroke are associated with worse outcome. Stroke (2011) 1.95
Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev (2014) 1.76
Serum biomarkers of brain injury to classify outcome after pediatric cardiac arrest*. Crit Care Med (2014) 1.52
Identification of Site-Specific Stroke Biomarker Candidates by Laser Capture Microdissection and Labeled Reference Peptide. Int J Mol Sci (2015) 1.46
A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma (2009) 1.39
Blood biomarkers of ischemic stroke. Neurotherapeutics (2011) 1.34
Recombinant T cell receptor ligand treats experimental stroke. Stroke (2009) 1.33
Successful microbubble sonothrombolysis without tissue-type plasminogen activator in a rabbit model of acute ischemic stroke. Stroke (2011) 1.28
Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest. Brain Res (2008) 1.15
Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab Brain Dis (2011) 1.09
Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol (2013) 1.09
Plasma glial fibrillary acidic protein levels in children with sickle cell disease. Am J Hematol (2011) 1.03
Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies. J Parkinsons Dis (2016) 0.97
Modulation of the postischemic immune response to improve stroke outcome. Stroke (2010) 0.93
Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med (2009) 0.92
The Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review. Aging Dis (2014) 0.90
Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia. J Pediatr (2012) 0.90
Correlation between Serum D-Dimer Level and Volume in Acute Ischemic Stroke. J Korean Neurosurg Soc (2011) 0.89
Anamnestic recall of stroke-related deficits: an animal model. Stroke (2010) 0.89
Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke. J Neuroinflammation (2011) 0.88
Diagnostic value of ischemia-modified albumin in acute coronary syndrome and acute ischemic stroke. Pak J Med Sci (2013) 0.88
Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma. PLoS One (2014) 0.87
Neuropsychological consequences of endarterectomy and endovascular angioplasty with stent placement for treatment of symptomatic carotid stenosis: a prospective randomised study. J Neurol (2007) 0.87
Antigen-specific immune reactions to ischemic stroke. Front Cell Neurosci (2014) 0.86
Biomarkers S100B and neuron-specific enolase predict outcome in hypothermia-treated encephalopathic newborns*. Pediatr Crit Care Med (2014) 0.85
Biomarkers for stroke. J Stroke (2013) 0.83
Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke. Ann Indian Acad Neurol (2013) 0.83
The immunologic profile of adoptively transferred lymphocytes influences stroke outcome of recipients. J Neuroimmunol (2013) 0.82
Activation of immune responses to brain antigens after stroke. J Neurochem (2012) 0.80
Peripheral biomarkers of stroke: Focus on circulatory microRNAs. Biochim Biophys Acta (2016) 0.80
Optimal therapeutic dose and time window of picroside II in cerebral ischemic injury. Neural Regen Res (2014) 0.79
Altered protein networks and cellular pathways in severe west nile disease in mice. PLoS One (2013) 0.79
A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study. BMC Neurol (2012) 0.79
Autoimmune responses to brain following stroke. Transl Stroke Res (2012) 0.78
Decreased Serum Levels of S-100B Protein Reflect Successful Treatment Effects in a Rabbit Model of Acute Ischemic Stroke. Open Neurol J (2011) 0.78
Thrombin antithrombin complex and IL-18 serum levels in stroke patients. Neurol Int (2010) 0.78
Biomarkers and acute brain injuries: interest and limits. Crit Care (2014) 0.77
Glial biomarkers in human central nervous system disease. Glia (2016) 0.77
Antigen Presentation After Stroke. Neurotherapeutics (2016) 0.76
Analyzing the Correlation between the Level of Serum Markers and Ischemic Cerebral Vascular Disease by Multiple Parameters. Comput Math Methods Med (2015) 0.75
SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases. Proteomics (2014) 0.75
Data for iTRAQ profiling of micro-vesicular plasma specimens: In search of potential prognostic circulatory biomarkers for Lacunar infarction. Data Brief (2015) 0.75
To study the correlation of serum S-100 protein level with the severity of stroke and its prognostic implication. J Neurosci Rural Pract (2015) 0.75
Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease. Proteomics Clin Appl (2014) 0.75
Prognostic value of somatosensory evoked potentials, neuron-specific enolase, and S100 for short-term outcome in ischemic stroke. J Neurophysiol (2015) 0.75
Apolipoprotein A1-Unique Peptide as a Diagnostic Biomarker for Acute Ischemic Stroke. Int J Mol Sci (2016) 0.75
The role of magnesium sulfate in the intensive care unit. EXCLI J (2017) 0.75
S100 B: A new concept in neurocritical care. Iran J Neurol (2017) 0.75
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke (2003) 7.75
The state of science and research in clinical pharmacy. Pharmacotherapy (2006) 7.26
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2008) 5.77
Stroke in a biracial population: the excess burden of stroke among blacks. Stroke (2004) 4.83
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord (2007) 3.86
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation (2002) 2.71
The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke (2006) 2.56
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke (2012) 2.46
Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke (2002) 2.36
Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02
SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol (2004) 1.94
Applying a phase II futility study design to therapeutic stroke trials. Stroke (2005) 1.89
Acculturation and diabetes among Hispanics: evidence from the 1999-2002 National Health and Nutrition Examination Survey. Public Health Rep (2006) 1.84
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke (2011) 1.80
The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke (2008) 1.79
Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke (2004) 1.78
Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic stroke. Am J Physiol Heart Circ Physiol (2013) 1.74
Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes (2005) 1.74
Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection. J Hypertens (2007) 1.71
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci (2006) 1.69
Streamlining of prehospital stroke management: the golden hour. Lancet Neurol (2013) 1.69
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Screening for brain aneurysm in the Familial Intracranial Aneurysm study: frequency and predictors of lesion detection. J Neurosurg (2008) 1.68
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol (2005) 1.67
Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke (2005) 1.65
Microvascular brain pathology and late-life motor impairment. Neurology (2013) 1.64
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke (2004) 1.60
Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work (2013) 1.59
Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke. J Hypertens (2015) 1.58
A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke. Ann Emerg Med (2012) 1.58
Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience. Mov Disord (2007) 1.55
NIHSS training and certification using a new digital video disk is reliable. Stroke (2005) 1.53
Clinical prediction of functional outcome after ischemic stroke: the surprising importance of periventricular white matter disease and race. Stroke (2008) 1.52
Emotional neglect in childhood and cerebral infarction in older age. Neurology (2012) 1.50
Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke (2005) 1.48
A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol (2005) 1.48
Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem. Biometrics (2005) 1.47
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol (2004) 1.47
Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program. Neurology (2013) 1.44
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med (2005) 1.44
Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 1.41
Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female Pelvic Med Reconstr Surg (2010) 1.41
Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol (2007) 1.41
Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia. Diabetes (2009) 1.40
Virtual TeleStroke support for the emergency department evaluation of acute stroke. Acad Emerg Med (2004) 1.39
Contemporary outcome measures in acute stroke research: choice of primary outcome measure and statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 1.39
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke (2010) 1.35
Surveillance of infectious disease occurrences in the community: an analysis of symptom presentation in the emergency department. Acad Emerg Med (2003) 1.33
Quasi-likelihood estimation for relative risk regression models. Biostatistics (2005) 1.31
Development of a measure to assess patient trust in medical researchers. Ann Fam Med (2006) 1.30
Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke (2009) 1.30
Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol (2003) 1.27
Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke (2005) 1.25
Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke (2007) 1.24
Comprehensive presurgical functional MRI language evaluation in adult patients with epilepsy. Epilepsy Behav (2007) 1.23
Minocycline for short-term neuroprotection. Pharmacotherapy (2006) 1.23
Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke (2009) 1.23
Angiogenesis: a harmonized target for recovery after stroke. Stroke (2012) 1.22
Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke (2010) 1.22
Correlates and predictors of colorectal cancer screening among male automotive workers. Cancer Epidemiol Biomarkers Prev (2007) 1.22
Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol (2002) 1.21
Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials. Neuroepidemiology (2011) 1.21
Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol (2012) 1.20
A coronary heart disease risk score based on patient-reported information. Am J Cardiol (2007) 1.19
West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation (2004) 1.18
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology (2013) 1.17
Recruiting older African American men to a cancer screening trial (the AAMEN Project). Gerontologist (2003) 1.16
Effect of untreated hypertension on hemorrhagic stroke. Stroke (2004) 1.16
Quantitation and localization of blood-to-brain influx by magnetic resonance imaging and quantitative autoradiography in a model of transient focal ischemia. Magn Reson Med (2005) 1.15
Impact of socioeconomic status on stroke incidence: a population-based study. Ann Neurol (2006) 1.15
Postpartum eclampsia complicated by reversible cerebral herniation. Obstet Gynecol (2006) 1.15
Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. Vascul Pharmacol (2009) 1.14
Intention to be screened over time for colorectal cancer in male automotive workers. Cancer Epidemiol Biomarkers Prev (2003) 1.13
Recruitment of African Americans with type 2 diabetes to a randomized controlled trial using three sources. Ethn Health (2002) 1.12
Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann Behav Med (2010) 1.12
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke (2013) 1.11
Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke (2008) 1.11
Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci (2005) 1.11
A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis (2008) 1.11
Microcatheter contrast injections during intra-arterial thrombolysis increase intracranial hemorrhage risk. J Neurointerv Surg (2010) 1.10
Retention of under-represented minorities in drug abuse treatment studies. Clin Trials (2009) 1.10